Skip to main content
TipRanks
Go Ultimate75% OFF

Syros Pharmaceuticals (0S90) Q2 2025 Earnings Report

2 Followers

DE:0S90 Q2 2025 EPS Results

Actual EPS
―
Consensus EPS
-EUR 0.21
Beat/Miss
―
One Year Ago EPS
-EUR 0.54

DE:0S90 Q2 2025 Revenue Results

Actual Revenue
―
Expected Revenue
EUR 0
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2025
Date
07/31/2025
Time
TBA
Conference Call
Thursday, July 31, 2025

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:0S90 Earnings History

DE:0S90 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20252025 (Q3)―--0.15―
Jul 31, 20252025 (Q2)-0.21--0.54―
May 01, 20252025 (Q1)-0.34-0.34-0.09-280.00% (-0.25)
Mar 06, 20252024 (Q4)-0.59-0.59-1.9870.18% (+1.39)
Oct 31, 20242024 (Q3)-0.61-0.15-1.388.81% (+1.15)
Jul 31, 20242024 (Q2)-0.70-0.54-1.1854.62% (+0.64)
May 14, 20242024 (Q1)-0.77-0.09-0.7788.24% (+0.68)
Mar 27, 20242023 (Q4)-1.04-1.98-0.15-1182.35% (-1.82)
Nov 14, 20232023 (Q3)-1.03-1.30-2.9155.45% (+1.61)
Aug 08, 20232023 (Q2)-1.02-1.18-4.975.93% (+3.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed